Reply: GDNF poses troubling questions for doctors, drug maker [3]

John T. Slevin, Greg A. Gerhardt, Charles D. Smith, Don M. Gash, A. Byron Young

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Reply: GDNF poses troubling questions for doctors, drug maker [3]'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science